Evaluating the Effectiveness of a Personalized Therapeutics Clinic (PTC) Intervention on Drug-Drug Interactions (DDIs) and Drug-Gene Interactions (DGIs)

Summary

The purpose of this study is to determine whether a consultation with a Personalized Therapeutics Clinic, or PTC, will help participants lower the risk for side effects (drug-drug interactions and drug-gene interactions) when taking many medications and help providers improve prescribing decisions for participants. A PTC is a clinical that will test your genes to gather information about your health that may help guide prescribing advice and offer you new information about your prescriptions. Doctors leading this study will look for variations (differences) in your genes that may suggest that you are at greater risk of having side effects or a greater chance of benefiting from certain medications. Individuals in this study will participate for roughly 9 months.

Eligibility

Age range

18+ years

Sex

All

Healthy volunteers

No

Interventions

• Other
  Drug-Drug Interaction Profile

  A profile based on genetic testing that shows information about how the participant's medications they are taking interact with each other.

• Other
  Drug-Gene Interaction Profile

  A profile based on genetic testing that shows information about how the participant's genes interact with/respond to certain medications they are taking.

• Other
  Standard of Care

  The standard treatment and prescribing for the participant's specific type of cancer.

Location